65 related articles for article (PubMed ID: 32266533)
1. High level of TILs is an independent predictor of negative sentinel lymph node in women but not in men.
Fortes C; Mastroeni S; Caggiati A; Passarelli F; Ricci F; Michelozzi P
Arch Dermatol Res; 2021 Jan; 313(1):57-61. PubMed ID: 32266533
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for sentinel lymph node metastasis in Korean acral and non-acral melanoma patients.
Song JY; Ryu YJ; Lee HK; Lee DH; Choi YD; Shim HJ; Yun SJ
Pigment Cell Melanoma Res; 2024 May; 37(3):332-342. PubMed ID: 38013393
[TBL] [Abstract][Full Text] [Related]
3. Macroscopic tumor dimension, sentinel lymph node outcome, and survival analysis among cutaneous melanoma.
Asato MA; Moraes-Neto FA; Moraes MPT; Ocanha-Xavier JP; Alencar Marques ME; Xavier-Junior JCC
Int J Dermatol; 2024 Jun; 63(6):765-772. PubMed ID: 38217520
[TBL] [Abstract][Full Text] [Related]
4. Proposal for the applicability of modified Breslow (measured from the basal membrane) as a predictor of survival and sentinel lymph node outcome in patients with cutaneous melanoma.
Asato MA; Moares Neto FA; Moraes MPT; Ocanha-Xavier JP; Takita LC; Marques MEA; Xavier-Júnior JCC
An Bras Dermatol; 2024; 99(3):398-406. PubMed ID: 38378363
[TBL] [Abstract][Full Text] [Related]
5. Spatial Proximity and Relative Distribution of Tumor-Infiltrating Lymphocytes and Macrophages Predict Survival in Melanoma.
De Logu F; Ugolini F; Iannone LF; Simi S; Maio V; de Giorgi V; Maria di Giacomo A; Miracco C; Cossu A; Palmieri G; Mandalà M; Massi D
Lab Invest; 2023 Dec; 103(12):100259. PubMed ID: 37839638
[TBL] [Abstract][Full Text] [Related]
6. The prognostic value of the histological shape of tumor negative sentinel nodes in breast cancer.
Kooreman LFS; Dieleman S; van Kuijk SMJ; Zur Hausen A; Smidt ML; Grabsch HI
Front Immunol; 2023; 14():1258641. PubMed ID: 37965336
[TBL] [Abstract][Full Text] [Related]
7. Tumor infiltrating lymphocytes in lymph node metastases of stage III melanoma correspond to response and survival in nine patients treated with ipilimumab at the time of stage IV disease.
Diem S; Hasan Ali O; Ackermann CJ; Bomze D; Koelzer VH; Jochum W; Speiser DE; Mertz KD; Flatz L
Cancer Immunol Immunother; 2018 Jan; 67(1):39-45. PubMed ID: 28894934
[TBL] [Abstract][Full Text] [Related]
8. Tumor width and calculated tumor area do not outperform Breslow thickness in predicting sentinel lymph node biopsy positivity.
Meves A; Todd A; Johnson EF
J Am Acad Dermatol; 2023 Jul; 89(1):188-190. PubMed ID: 36948300
[No Abstract] [Full Text] [Related]
9. Influence of regression, its extent and tumor-infiltrating lymphocytes on sentinel node status, relapse, and survival in a 10-year retrospective study of melanoma patients.
Maione V; Perantoni M; Bettolini L; Bighetti S; Arisi M; Tomasi C; Incardona P; Calzavara-Pinton P
Melanoma Res; 2024 May; ():. PubMed ID: 38564432
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of B-cell density in cutaneous melanoma.
Ladányi A; Kiss J; Mohos A; Somlai B; Liszkay G; Gilde K; Fejös Z; Gaudi I; Dobos J; Tímár J
Cancer Immunol Immunother; 2011 Dec; 60(12):1729-38. PubMed ID: 21779876
[TBL] [Abstract][Full Text] [Related]
11. Presence of tumor-infiltrating lymphocytes and a dominant nodule within primary melanoma are prognostic factors for relapse-free survival of patients with thick (t4) primary melanoma: pathologic analysis of the e1690 and e1694 intergroup trials.
Rao UN; Lee SJ; Luo W; Mihm MC; Kirkwood JM
Am J Clin Pathol; 2010 Apr; 133(4):646-53. PubMed ID: 20231618
[TBL] [Abstract][Full Text] [Related]
12. Relationships between tumor thickness and the risk of sentinel node metastasis in acral and non-acral melanoma.
Kato J; Hida T; Kamiya T; Horimoto K; Sato S; Sawada M; Minowa T; Handa T; Komatsu S; Uhara H
Int J Dermatol; 2023 Nov; 62(11):e573-e575. PubMed ID: 37387547
[No Abstract] [Full Text] [Related]
13. Gender differences in pediatric and adolescent melanoma: A retrospective analysis of 4645 cases.
Fernandez JM; Koblinski JE; Dahak S; Curiel-Lewandrowski C; Thiede R
J Am Acad Dermatol; 2024 Feb; 90(2):280-287. PubMed ID: 37802183
[TBL] [Abstract][Full Text] [Related]
14. Tumor-infiltrating lymphocytes as a prognostic and predictive factor for Melanoma.
Vargas GM; Shafique N; Xu X; Karakousis G
Expert Rev Mol Diagn; 2024 Apr; 24(4):299-310. PubMed ID: 38314660
[TBL] [Abstract][Full Text] [Related]
15. Melanoma-specific survival is worse in the elderly: a multicentric cohort study.
Segura S; Podlipnik S; Boada A; Martí RM; Sabat M; Yélamos O; Zarzoso-Muñoz I; Azón-Masoliver A; López-Castillo D; Solà J; Baliu-Piqué C; Galvany-Rossell L; Pasquali P; Just-Sarobé M; Duran X; Carrera C; Richarz NA; Pujol RM; Malvehy J; Puig S;
Melanoma Res; 2023 Dec; 33(6):532-538. PubMed ID: 37696262
[TBL] [Abstract][Full Text] [Related]
16. Tumor-infiltrating lymphocytes: apparently good for melanoma patients. But why?
Cipponi A; Wieers G; van Baren N; Coulie PG
Cancer Immunol Immunother; 2011 Aug; 60(8):1153-60. PubMed ID: 21553145
[TBL] [Abstract][Full Text] [Related]
17. Density of high endothelial venules and PDL-1 expression: relationship with tumor-infiltrating lymphocytes in primary cutaneous melanomas.
Stolfo JB; Motta ACD
An Acad Bras Cienc; 2024; 96(1):e20230441. PubMed ID: 38511744
[TBL] [Abstract][Full Text] [Related]
18. Online prediction tools for melanoma survival: A comparison.
Dixon A; Steinman HK; Kyrgidis A; Smith H; Sladden M; Zouboulis C; Argenziano G; Apalla Z; Lallas A; Longo C; Nirenberg A; Popescu C; Tzellos T; Cleaver L; Zachary C; Anderson S; Thomas JM
J Eur Acad Dermatol Venereol; 2023 Oct; 37(10):1999-2003. PubMed ID: 37210649
[TBL] [Abstract][Full Text] [Related]
19. Immune cell populations in the tumour environment following calcium electropora-tion for cutaneous metastasis: a histopathological study.
Vissing M; Sinius Pouplier S; Munch Larsen L; Krog Frandsen S; Lodin A; Lænkholm AV; Gehl J
Acta Oncol; 2024 May; 63():398-410. PubMed ID: 38804839
[TBL] [Abstract][Full Text] [Related]
20. Tumoral inflammatory infiltrate does not predict metastases in thin primary cutaneous melanomas.
Bevilaqua M; Rey MCW; Cappellini GCA; Riccardi F; Fortes C; Roehe AV; Bonamigo RR
An Bras Dermatol; 2023; 98(6):793-798. PubMed ID: 37355350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
